Literature DB >> 10567198

Time-dependent effects of the neuropeptide PACAP on catecholamine secretion : stimulation and desensitization.

L Taupenot1, M Mahata, S K Mahata, D T O'Connor.   

Abstract

Pituitary adenylyl cyclase-activating polypeptide (PACAP) is a potent endogenous secretagogue for chromaffin cells. We previously reported that PACAP coupled to the PAC1 receptor to evoke dihydropyridine-sensitive early (15 to 20 minutes) catecholamine secretion and cAMP response element binding protein-mediated trans-activation of the secretory protein chromogranin A promoter in PC12 pheochromocytoma cells. In this report, we studied whether the secretory and transcriptional responses elicited by PACAP were subject to desensitization. We found that PACAP evoked distinct immediate (initial, 0 to 20 minutes) and long-lasting (20 to 180 minutes) effects on catecholamine secretion. Initial secretory and chromogranin A trans-activation responses induced by PACAP were desensitized in a dose-dependent fashion after preexposure of cells to PACAP, and the IC(50) doses of PACAP for desensitization were approximately 18- to approximately 32-fold lower than the EC(50) activating doses for secretion or transcription. Desensitization of the initial secretion response was associated with decreased Ca(2+) influx through L-type voltage-operated Ca(2+) channels. Acute exposure to PACAP also triggered long-lasting (up to 3 hours), extracellular Ca(2+)-dependent, pertussis toxin-insensitive catecholamine secretion; indeed, even after short-term (20 minutes) exposure to PACAP and removal of the secretagogue, PC12 cells continued to secrete norepinephrine up to 76.9+/-0.22% of cellular norepinephrine content after 3 hours. A phospholipase C-beta inhibitor (U-73122) blocked this extended secretory response, which was dependent on low-magnitude Ca(2+) influx resistant to several L-, N-, P/Q-, or T-type Ca(2+) channel antagonists, but sensitive to Zn(2+), Ni(2+), Cd(2+), or to the store-operated Ca(2+) channel blocker SKF96365. A less than additive effect of the sarco-endoplasmic reticulum Ca(2+)-ATPase inhibitor thapsigargin plus PACAP on this sustained secretion also supported a contribution of store-operated Ca(2+) entry to the sustained secretory response. We propose that PACAP-evoked secretion and transcription are subject to homologous desensitization in PC12 cells; however, PACAP also induces long-lasting secretion, even under dose and time circumstances in which acute, dihydropyridine-sensitive secretion has been desensitized. Although initial secretion is mediated by an L-type voltage-operated Ca(2+) channel, extended secretion may involve a store-operated Ca(2+) channel that is activated through a G(q/11)/phospholipase C-beta/phosphoinositide signaling pathway.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10567198     DOI: 10.1161/01.hyp.34.5.1152

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  20 in total

1.  Pituitary adenylate cyclase-activating peptide (PACAP) recruits low voltage-activated T-type calcium influx under acute sympathetic stimulation in mouse adrenal chromaffin cells.

Authors:  Jacqueline Hill; Shyue-An Chan; Barbara Kuri; Corey Smith
Journal:  J Biol Chem       Date:  2011-10-18       Impact factor: 5.157

2.  PAC1hop receptor activation facilitates catecholamine secretion selectively through 2-APB-sensitive Ca(2+) channels in PC12 cells.

Authors:  Tomris Mustafa; James Walsh; Maurizio Grimaldi; Lee E Eiden
Journal:  Cell Signal       Date:  2010-05-12       Impact factor: 4.315

3.  P2Y2 receptor activates nerve growth factor/TrkA signaling to enhance neuronal differentiation.

Authors:  David B Arthur; Katerina Akassoglou; Paul A Insel
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

4.  The hop cassette of the PAC1 receptor confers coupling to Ca2+ elevation required for pituitary adenylate cyclase-activating polypeptide-evoked neurosecretion.

Authors:  Tomris Mustafa; Maurizio Grimaldi; Lee E Eiden
Journal:  J Biol Chem       Date:  2007-01-09       Impact factor: 5.157

5.  Genetic variation within a metabolic motif in the chromogranin a promoter: pleiotropic influence on cardiometabolic risk traits in twins.

Authors:  Fangwen Rao; Stephane Chiron; Zhiyun Wei; Maple M Fung; Yuqing Chen; Gen Wen; Srikrishna Khandrika; Michael G Ziegler; Beben Benyamin; Grant Montgomery; John B Whitfield; Nicholas G Martin; Jill Waalen; Bruce A Hamilton; Sushil K Mahata; Daniel T O'Connor
Journal:  Am J Hypertens       Date:  2011-09-15       Impact factor: 2.689

6.  Sorting of the neuroendocrine secretory protein Secretogranin II into the regulated secretory pathway: role of N- and C-terminal alpha-helical domains.

Authors:  Maïté Courel; Michael S Vasquez; Vivian Y Hook; Sushil K Mahata; Laurent Taupenot
Journal:  J Biol Chem       Date:  2008-02-25       Impact factor: 5.157

7.  Receptors for NPY and PACAP differ in expression and activity during adipogenesis in the murine 3T3-L1 fibroblast cell line.

Authors:  Martin T Gericke; Joanna Kosacka; Daniela Koch; Marcin Nowicki; Thomas Schröder; Albert M Ricken; Karen Nieber; Katharina Spanel-Borowski
Journal:  Br J Pharmacol       Date:  2009-04-27       Impact factor: 8.739

8.  A cAMP-dependent, protein kinase A-independent signaling pathway mediating neuritogenesis through Egr1 in PC12 cells.

Authors:  Aurélia Ravni; David Vaudry; Matthew J Gerdin; Maribeth V Eiden; Anthony Falluel-Morel; Bruno J Gonzalez; Hubert Vaudry; Lee E Eiden
Journal:  Mol Pharmacol       Date:  2008-03-24       Impact factor: 4.436

9.  Heritability and genome-wide linkage in US and australian twins identify novel genomic regions controlling chromogranin a: implications for secretion and blood pressure.

Authors:  Daniel T O'Connor; Gu Zhu; Fangwen Rao; Laurent Taupenot; Maple M Fung; Madhusudan Das; Sushil K Mahata; Manjula Mahata; Lei Wang; Kuixing Zhang; Tiffany A Greenwood; Pei-an Betty Shih; Myles G Cockburn; Michael G Ziegler; Mats Stridsberg; Nicholas G Martin; John B Whitfield
Journal:  Circulation       Date:  2008-06-30       Impact factor: 29.690

10.  Common genetic variants in the chromogranin A promoter alter autonomic activity and blood pressure.

Authors:  Y Chen; F Rao; J L Rodriguez-Flores; N R Mahapatra; M Mahata; G Wen; R M Salem; P-A B Shih; M Das; N J Schork; M G Ziegler; B A Hamilton; S K Mahata; D T O'Connor
Journal:  Kidney Int       Date:  2008-04-23       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.